# Preoperative Chemoradiation for Glioblastoma

> **NCT02092038** · PHASE1 · COMPLETED · sponsor: **Tampa General Hospital** · enrollment: 1 (actual)

## Conditions studied

- Glioblastoma

## Interventions

- **DRUG:** Temozolomide
- **RADIATION:** partial brain irradiation
- **PROCEDURE:** stereotactic biopsy of brain tumor
- **PROCEDURE:** craniotomy and tumor resection

## Key facts

- **NCT ID:** NCT02092038
- **Lead sponsor:** Tampa General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2015-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02092038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02092038, "Preoperative Chemoradiation for Glioblastoma". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT02092038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*